Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
- PMID: 35955815
- PMCID: PMC9369368
- DOI: 10.3390/ijms23158680
Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
Abstract
The vast amount of epidemiologic and genomic data that were gathered as a global response to the COVID-19 pandemic that was caused by SARS-CoV-2 offer a unique opportunity to shed light on the structural evolution of coronaviruses and in particular on the spike (S) glycoprotein, which mediates virus entry into the host cell by binding to the human ACE2 receptor. Herein, we carry out an investigation into the dynamic properties of the S glycoprotein, focusing on the much more transmissible Delta and Omicron variants. Notwithstanding the great number of mutations that have accumulated, particularly in the Omicron S glycoprotein, our data clearly showed the conservation of some structural and dynamic elements, such as the global motion of the receptor binding domain (RBD). However, our studies also revealed structural and dynamic alterations that were concentrated in the aa 627-635 region, on a small region of the receptor binding motif (aa 483-485), and the so-called "fusion-peptide proximal region". In particular, these last two S regions are known to be involved in the human receptor ACE2 recognition and membrane fusion. Our structural evidence, therefore, is likely involved in the observed different transmissibility of these S mutants. Finally, we highlighted the role of glycans in the increased RBD flexibility of the monomer in the up conformation of Omicron.
Keywords: COVID-19; SARS-CoV-2; delta; molecular dynamics; omicron; spike; variants.
Conflict of interest statement
The authors declare no conflict of interest.
Figures








Similar articles
-
The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.Int J Mol Sci. 2022 Nov 4;23(21):13502. doi: 10.3390/ijms232113502. Int J Mol Sci. 2022. PMID: 36362302 Free PMC article.
-
A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.Front Immunol. 2022 Dec 9;13:954435. doi: 10.3389/fimmu.2022.954435. eCollection 2022. Front Immunol. 2022. PMID: 36569921 Free PMC article.
-
A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants.Biomolecules. 2022 Oct 31;12(11):1607. doi: 10.3390/biom12111607. Biomolecules. 2022. PMID: 36358957 Free PMC article.
-
Structural basis of severe acute respiratory syndrome coronavirus 2 infection.Curr Opin HIV AIDS. 2021 Jan;16(1):74-81. doi: 10.1097/COH.0000000000000658. Curr Opin HIV AIDS. 2021. PMID: 33186231 Review.
-
COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2.PLoS Pathog. 2020 Aug 21;16(8):e1008762. doi: 10.1371/journal.ppat.1008762. eCollection 2020 Aug. PLoS Pathog. 2020. PMID: 32822426 Free PMC article. Review.
Cited by
-
Exscalate4CoV: Innovative High Performing Computing (HPC) Strategies to Tackle Pandemic Crisis.Int J Mol Sci. 2022 Sep 30;23(19):11576. doi: 10.3390/ijms231911576. Int J Mol Sci. 2022. PMID: 36232873 Free PMC article.
-
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants.PLoS Pathog. 2023 Nov 9;19(11):e1011788. doi: 10.1371/journal.ppat.1011788. eCollection 2023 Nov. PLoS Pathog. 2023. PMID: 37943965 Free PMC article.
-
Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients.Biomolecules. 2023 Oct 18;13(10):1538. doi: 10.3390/biom13101538. Biomolecules. 2023. PMID: 37892220 Free PMC article.
-
MD-Ligand-Receptor: A High-Performance Computing Tool for Characterizing Ligand-Receptor Binding Interactions in Molecular Dynamics Trajectories.Int J Mol Sci. 2023 Jul 19;24(14):11671. doi: 10.3390/ijms241411671. Int J Mol Sci. 2023. PMID: 37511429 Free PMC article.
-
The Spike Mutants Website: A Worldwide Used Resource against SARS-CoV-2.Int J Mol Sci. 2022 Oct 28;23(21):13082. doi: 10.3390/ijms232113082. Int J Mol Sci. 2022. PMID: 36361870 Free PMC article.
References
-
- World Health Organization. [(accessed on 26 May 2022)]. Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants.
-
- Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., et al. The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV and Naming It SARS-CoV-2. Nat. Microbiol. 2020;5:536–544. doi: 10.1038/s41564-020-0695-z. - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
- H2020-SC1-PHE-CORONAVIRUS-2020/EU
- Departments of Excellence-2018' Program (Dipartimenti di Eccellenza) to DIBAF-Department of University of Tuscia, Project 'Landscape 4.0-food, wellbeing and environment'./Ministry of Education, Universities and Research
- Project 5M-2020-23682104/Ministero della Salute, 5 per Mille
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous